QuoteMedia, Inc. (OTCBB: QMCI), IMAX Corporation (NASD: IMAX), Edgeline Holdings, Inc. (OTCBB:ELHI), MM2 Group, Inc. (OTCBB: MMGP)
Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://qmci.realpennies.com
QUOTEMEDIA INC. (OTCBB: QMCI)
QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, please visit: www.quotemedia.com.
QMCI News:
December 5 - QuoteMedia Brings Respected Market Data Industry Veteran Onboard; Opens NYC Office
QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data, corporate research information and financial applications, announced today the appointment of Mr. George Katsch as Corporate Sales Director, to lead the company's new office in New York City.
Mr. Katsch brings more than 15 years of experience in selling and supporting financial information and technology solutions to the Brokerage, Financial Service, Media Publishing and Investor Relations industries. Most recently, Mr. Katsch served as Vice President of Sales for FinancialContent, Inc., where he was responsible for business development and sales for the entire North American market. Mr. Katsch has also held key management positions with Standard and Poor's and Interactive Data Corporation (Comstock), where he managed senior account representatives and support staff. He was principally responsible for maintaining over $50 million in revenues and generating new sales.
"George is very well-known as a successful, skilled professional in our industry, and we're excited that he is joining the QuoteMedia sales team, heading up our New York office," said Dave Shworan, CEO of QuoteMedia Ltd. "He brings a wealth of experience to our company, and skill sets that make him an immediately great fit with QuoteMedia, as we continue our explosive growth."
"From within the industry, I've watched QuoteMedia's remarkable growth over the past few years. I have been very impressed with QuoteMedia's emergence as a major player in the financial data industry, and the potential for further growth is extraordinary," said Mr. Katsch. "QuoteMedia is definitely going places, and I'm excited to be a part of it."
IMAX CORPORATION (NASD: IMAX) "Up 56.90% in morning trading"
For more info: http://imax.realpennies.com
IMAX Corporation, through its wholly owned subsidiaries, operates as an entertainment technology company. It specializes in digital and film-based motion picture technologies and large-format two-dimensional (2D) and three-dimensional (3D) film presentations. The company primarily engages in the design, manufacture, sale, and lease of theater systems based on patented technology for large-format, 15-perforation film frame, 70mm format theaters, including commercial theaters, museums and science centers, and destination entertainment sites. Its theater systems include projector, sound systems, and screens. IMAX Corporation also designs and manufactures high-end sound systems, as well as produces and distributes films for IMAX theaters. In addition, the company engages in the production, digital re-mastering, post-production, and distribution of 15/70-format films; the operation of IMAX theaters; and the provision of services in support of IMAX theaters and the IMAX theater network. Its institutional customers include science and natural history museums, zoos, aquaria, and other educational and cultural centers. The company also sells or leases its theater systems to theme parks, tourist destination sites, fairs, and expositions. It operates primarily in the United States, Canada, Mexico, Europe, and Asia. As of March 31, 2007, IMAX Corporation operated 284 IMAX theaters in 40 countries. The company was founded in 1967 and is headquartered in Mississauga, Canada.
IMAX News:
December 7 - IMAX signs 100-theatre deal with AMC EntertainmentTM
IMAX Corporation (NASD: IMAX) (TSX: IMX) and AMC Entertainment Inc. (AMC), one of the world's largest and most innovative theatrical exhibition companies, announced a joint-venture agreement to install 100 IMAX digital projection systems at AMC locations in 33 major U.S. markets. The theatres will feature IMAX's digital projection system which is being developed for the IMAX MPX theatre design. The agreement is projected to double IMAX's current commercial theatre footprint in North America and accelerates the momentum behind IMAX and AMC's transition to digital projection technology.
"We are committed to delivering a premium entertainment experience by offering a menu of entertainment alternatives inside our facilities," said Peter C. Brown, chairman and chief executive officer, AMC Entertainment Inc. "Our expanded relationship with IMAX and the deployment of its state-of-the-art, next-generation digital projection systems is a key part of our strategy of continuing to broaden and enhance the AMC experience. It also builds on the successful partnership we have had with IMAX since June of 2005 and complements our overall digital plan."
The rollout of the first 50 IMAX digital projection systems will begin in July 2008 at premier AMC theatre locations in 24 of the 33 selected markets, with an additional 25 scheduled for rollout in 2009 and 25 more in 2010. The IMAX theatres are slated to be installed in many of AMC's top-performing locations in the United States, including: AMC South Barrington 30, Chicago; AMC Mesquite 30, Dallas; AMC Gulf Pointe 30, Houston; AMC Century City 15, Los Angeles; AMC Empire 25, New York; AMC Neshaminy 24, Philadelphia; AMC Eastridge 15, San Francisco; AMC Hoffman Center 22, Washington D.C.
"The agreement cements a partnership between two great brands. Partnering with AMC in a theatre deal of this size and scope is a transformational moment for our company from both a financial and strategic perspective," said IMAX Co-Chairmen and Co-CEOs Richard L. Gelfond and Bradley J. Wechsler. "We couldn't be more pleased that The IMAX Experience will be more accessible to consumers in nearly every major market in the United States. AMC is unique in the number of successful, stadium-seat megaplexes in locations that could accommodate this large number of new IMAX theatres. Further, AMC's confidence in our digital projection system is a terrific endorsement. We look forward to rolling out our ground-breaking new technology and delivering the premium experience that moviegoers have come to expect from the IMAX brand."
In October of this year, IMAX announced that it had moved up the launch date of its digital projection system to mid-2008 from its previously announced anticipated timeframe of the end of 2008 to mid-2009. The highly anticipated IMAX digital projection system will further enhance The IMAX Experience and help to drive profitability for studios, exhibitors and IMAX theatres by virtually eliminating the need for film prints, increasing program flexibility and ultimately increasing the number of movies shown on IMAX screens.
IMAX has already secured important parts of its film slate for 2008, 2009 and 2010 through agreements with major Hollywood studios including: The Spiderwick Chronicles (February 2008), Shine A Light (April 2008), Kung Fu Panda (June 2008), The Dark Knight (July 2008), Deep Sea-quel 3D (working title, February 2009), Monsters vs. Aliens 3D (March 2009), How to Train Your Dragon 3D (November 2009), Hubble 3D (working title, February 2010) and Shrek Goes Forth 3D (May 2010).
Added Messrs. Gelfond and Wechsler, "An agreement of this magnitude significantly jumpstarts our joint venture initiative, which we expect will generate increased recurring revenues for IMAX going forward. AMC's decision to enter into this agreement will accelerate the growth of our theatre network in North America and should help power the digital transition underway at our company, which we believe will help drive our operating and financial performance for years to come."
About AMC Entertainment Inc.
Headquartered in Kansas City, Mo., AMC Entertainment Inc. is one of the world's largest and most innovative theatrical exhibition companies. With a history of industry leadership dating back to 1920, the company today serves more than 230 million guests annually through interests in 358 theatres with 5,128 screens in six countries. Visit www.amctheatres.com for more information.
EDGELINE HOLDINGS (OTCBB: ELHI) "Up 34.88% in morning trading"
For more info: http://elhi.realpennies.com
Headquartered in Houston, Texas, Edgeline Holdings, Inc. is a publicly traded holding company that specializes in the area of discovering and acquiring leading-edge niche technologies. These technologies will be incubated and nurtured into market ready applications. Edgeline's current and prospective portfolio consists of early stage companies that require management expertise to further develop the technology to ultimately maximize the value of such technologies by bringing them to market through licensing arrangements and partnerships.
ELHI News:
December 5 - Edgeline Holdings Signs Exclusive Option Agreement with The University of Texas M. D. Anderson Cancer Center
Edgeline Holdings, Inc. (OTCBB:ELHI) announced today that it has signed an Option agreement with The University of Texas M. D. Anderson Cancer Center that provides Edgeline Holdings the exclusive right to negotiate a license to five technologies relating to the treatment of various cancers over a nine month period. During this period the company has the right to evaluate the patents rights, potential products and markets, and to negotiate a license for the use of these patents.
"This agreement gives us the necessary time to allow our subsidiary, Intertech Bio, to properly evaluate the potential of these technologies," stated Leonard Ivins, Chief Executive Officer of Edgeline Holdings. "M. D. Anderson has been a leader in developing new cancer therapies and we are excited about the opportunity to work with such a great institution."
MM2 GROUP, INC (OTCBB: MMGP) "Up 13.33% in morning trading"
For more info: http://mmgp.realpennies.com
MM2 Group, Inc., through its subsidiary, Genotec Nutritionals, Inc., engages in the formulation, marketing, and distribution of nutritional supplements and vitamins in the United States. It sells various products, including fish oil, grape powder, resveratrol, lutein, and psyllium powder, as well as various custom formulations, such as formulations for diet, cardiac support, eye support, immunity support, and aging support. The company also sells custom formulations for pet care, including a shedding formula, a coat formula, dog and cat joint formulas, and pet multi-vitamins for dogs and cats. MM2 Group is based in Livingston, New Jersey.
MMGP News:
December 7 - MM2 Group Establishes New Venture for Sofgel Manufacture in China
MM2 Group, Inc. (OTCBB: MMGP) announced that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has entered into a strategic venture to manufacture sofgel capsules in Zhongsan City, China.
The current capacity of the state of the art plant is 1.5 billion capsules per year. The plant was designed and built according to the latest cGMP requirements, in full compliance with both U.S. and China standards. The plant is capable of expanding capacity to 5 billion sofgel capsules per year.
Genotec's partner in this new venture is Anshi Pharmaceutical (Zhongsan) Inc. of China.
Anshi Pharmaceutical is a well regarded company in China. Its Executive Chairman, Mr. Xiaoxian Xu, is a famous entrepreneur in China who previously founded Livzon Pharmaceutical Group, a well known publicly-traded pharmaceutical company in China. Anshi is well positioned to provide research and development, manufacturing, and export services to the pharmaceutical and nutraceutical industries in the United States.
George Kontonotas, President of Genotec, stated, "We are very excited about this venture. The plant is a China SFDA certified facility that complies with cGMP manufacturing standards. These high standards, which allow the plant to currently manufacture pharmaceuticals, make this among the highest quality plants which can be found manufacturing products in the nutritional supplement marketplace."
Mark Meller, CEO of MM2 Group, commented, "We have already met with some of the largest users of sofgels in the nutritional supplement market. Our current focus is to supply large quantities of Vitamin E capsules to several users. We are now negotiating supply agreements with various companies, and hope to be in a position to make several exciting announcements in the near future regarding sales activity from this new venture."
Meller continued, "We are excited about our business prospects. We recently announced net income of $951,855 for our fiscal first quarter, up from a loss of $1,379,761 in the same period last year. We announced last week that we secured a large $1.1 million order for our omega-3 fish oil sofgels. We also recently announced a listing on the Frankfurt Stock Exchange, which we expect will give us greater visibility in Europe and will provide us with an opportunity to broaden our shareholder base to Europe. We anticipate that we will be in a position to announce more exciting business developments in the near future."
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
No comments:
Post a Comment